Literature DB >> 29678669

Using Big Data in oncology to prospectively impact clinical patient care: A proof of concept study.

Vérène Dougoud-Chauvin1, Jae Jin Lee1, Edgardo Santos2, Vonetta L Williams1, Nicolò M L Battisti1, Kavita Ghia1, Marina Sehovic1, Cortlin Croft1, Jongphil Kim1, Lodovico Balducci1, Julie A Kish1, Martine Extermann3.   

Abstract

OBJECTIVE: Big Data is widely seen as a major opportunity for progress in the practice of personalized medicine, attracting the attention from medical societies and presidential teams alike as it offers a unique opportunity to enlarge the base of evidence, especially for older patients underrepresented in clinical trials. This study prospectively assessed the real-time availability of clinical cases in the Health & Research Informatics Total Cancer Care™ (TCC) database matching community patients with cancer, and the impact of such a consultation on treatment.
MATERIALS AND METHODS: Patients aged 70 and older seen at the Lynn Cancer Institute (LCI) with a documented malignancy were eligible. Geriatric screening information and the oncologist's pre-consultation treatment plan were sent to Moffitt. A search for similar patients was done in TCC and additional information retrieved from Electronic Medical Records. A report summarizing the data was sent and the utility of such a consultation was assessed per email after the treatment decision.
RESULTS: Thirty one patients were included. The geriatric screening was positive in 87.1% (27) of them. The oncogeriatric consultation took on average 2.2 working days. It influenced treatment in 38.7% (12), and modified it in 19.4% (6). The consultation was perceived as "somewhat" to "very useful" in 83.9% (26).
CONCLUSION: This study establishes a proof of concept of the feasibility of real time use of Big Data for clinical practice. The geriatric screening and the consultation report influenced treatment in 38.7% of cases and modified it in 19.4%, which compares very well with oncogeriatric literature. Additional steps are needed to render it financially and clinically viable.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Big Data; Cancer; Elderly; Electronic consultation; Electronic database; Geriatric oncology; Health & Research Informatics; Personalized medicine; Precision medicine; Total Cancer Care

Mesh:

Year:  2018        PMID: 29678669      PMCID: PMC6192862          DOI: 10.1016/j.jgo.2018.03.017

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.599


  21 in total

1.  Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale.

Authors:  M D Miller; C F Paradis; P R Houck; S Mazumdar; J A Stack; A H Rifai; B Mulsant; C F Reynolds
Journal:  Psychiatry Res       Date:  1992-03       Impact factor: 3.222

2.  Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts.

Authors:  Bruce E Hillner; Barry A Siegel; Lucy Hanna; Anthony F Shields; Fenghai Duan; Ilana F Gareen; Bruce Quinn; R Edward Coleman
Journal:  J Nucl Med       Date:  2012-03-23       Impact factor: 10.057

3.  The inevitable application of big data to health care.

Authors:  Travis B Murdoch; Allan S Detsky
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

4.  Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study.

Authors:  Philippe Caillet; Florence Canoui-Poitrine; Johanna Vouriot; Muriel Berle; Nicoleta Reinald; Sebastien Krypciak; Sylvie Bastuji-Garin; Stephane Culine; Elena Paillaud
Journal:  J Clin Oncol       Date:  2011-06-27       Impact factor: 44.544

5.  The influence of clinical assessment (including age) and geriatric assessment on treatment decisions in older patients with cancer.

Authors:  Lore Decoster; Cindy Kenis; Katrien Van Puyvelde; Johan Flamaing; Godelieve Conings; Jacques De Grève; Tony Mets; Koen Milisen; Jean Pierre Lobelle; Hans Wildiers
Journal:  J Geriatr Oncol       Date:  2013-05-23       Impact factor: 3.599

6.  Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry.

Authors:  Bruce E Hillner; Barry A Siegel; Anthony F Shields; Dawei Liu; Ilana F Gareen; Ed Hunt; R Edward Coleman
Journal:  J Nucl Med       Date:  2008-11-07       Impact factor: 10.057

7.  Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?

Authors:  Véronique Girre; Marie-Christine Falcou; Mathilde Gisselbrecht; Geneviève Gridel; Véronique Mosseri; Carole Bouleuc; Rollon Poinsot; Lionel Vedrine; Liliane Ollivier; Valérie Garabige; Jean-Yves Pierga; Véronique Diéras; Laurent Mignot
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-07       Impact factor: 6.053

8.  Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.

Authors:  Bruce E Hillner; Barry A Siegel; Dawei Liu; Anthony F Shields; Ilana F Gareen; Lucy Hanna; Sharon Hartson Stine; R Edward Coleman
Journal:  J Clin Oncol       Date:  2008-03-24       Impact factor: 44.544

9.  Utility of Mini-Mental State Exam scores in predicting functional impairment among white and African American dementia patients.

Authors:  G R Ford; W E Haley; S L Thrower; C A West; L E Harrell
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1996-07       Impact factor: 6.053

10.  Intended versus inferred care after PET performed for initial staging in the National Oncologic PET Registry.

Authors:  Bruce E Hillner; Anna N Tosteson; Tor D Tosteson; Qianfei Wang; Yunjie Song; Lucy G Hanna; Barry A Siegel
Journal:  J Nucl Med       Date:  2013-11-12       Impact factor: 10.057

View more
  1 in total

1.  Cohort Identification for Translational Bioinformatics Studies.

Authors:  Tiffany A Lin; Zeynep Eroglu; Rodrigo Carvajal; Joseph Markowitz
Journal:  Methods Mol Biol       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.